Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 16/20 | 1.00 |
| ▸ | AXL | P30530 | 10/20 | 1.00 |
| ▸ | AURKA | O14965 | 1/20 | 1.00 |
| ▸ | ABL1 | P00519 | 1/20 | 1.00 |
| ▸ | LCK | P06239 | 1/20 | 1.00 |
| ▸ | SRC | P12931 | 1/20 | 1.00 |
| ▸ | FER | P16591 | 1/20 | 1.00 |
| ▸ | CDK8 | P49336 | 1/20 | 1.00 |
| ▸ | TYRO3 | Q06418 | 1/20 | 1.00 |
| ▸ | MERTK | Q12866 | 1/20 | 1.00 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 1.00 |
| ▸ | AURKB | Q96GD4 | 1/20 | 1.00 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL167963 | 1.00 | MET (1.00) | METAXLAURKAABL1LCK | |
| SCHEMBL29393648 | 1.00 | MET (1.00) | METAXLAURKAABL1LCK | |
| Hydrochloric Acid SCHEMBL21777779 | 0.99 | MET (0.99) | METAXLAURKAABL1LCK | |
| SCHEMBL166104 | 0.95 | MET (0.90) | METAXLAURKAABL1LCK | |
| SCHEMBL698578 | 0.95 | MET (0.90) | METAXLAURKAABL1LCK | |
| SCHEMBL168168 | 0.94 | MET (0.88) | METAXLAURKAABL1LCK | |
| SCHEMBL697401 | 0.93 | MET (0.87) | METAXLAURKAABL1LCK | |
| SCHEMBL167717 | 0.92 | MET (0.85) | METAXLAURKAABL1LCK | |
| SCHEMBL168511 | 0.91 | MET (0.84) | METAXLAURKAABL1LCK | |
| SCHEMBL20022575 | 0.91 | MET (0.83) | METAXLAURKAABL1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2023122577-A2 | METHODS OF TREATING CANCER USING LIPOSOMAL PARTICLES COMPRISING ANTICANCER AGENTS AND PHARMACEUTICAL COMPOSITIONS RELATED THERETO | EMORY UNIVERSITY (US) | 2023-06-29 | — | — | WO | disclosed |